Major histocompatibility complex class II peptide-binding groove (MHC class II peptide-binding groove)

The major histocompatibility complex class II peptide-binding groove is a specialized structural feature of MHC class II molecules, formed by the α1 and β1 domains of the two subunits. This groove is uniquely open at both ends, distinguishing it from MHC class I, and allows binding of peptides typically 13–25 residues long, with a conserved 9-mer core. The groove contains four principal anchoring pockets (P1, P4, P6, P9) that determine the affinity and specificity of the bound peptide. Peptide loading occurs in specialized endosomal compartments, and the groove is initially occupied by the invariant chain or its fragment CLIP, which is removed and exchanged for antigenic peptides by specialized cofactors. The presentation of these peptides on the cell surface by antigen-presenting cells is essential for activation of CD4+ helper T cells and the initiation of adaptive immune responses. Variants and polymorphisms of the MHC class II peptide-binding groove influence autoimmune susceptibility, infection resistance, and response to immunotherapeutics. Targeting peptide interaction with this groove is an attractive therapeutic strategy for modulating immune responses in autoimmunity, transplantation, infection, and cancer[1][2][3][4][5][6][7][10].

Other names

MHC-II peptide-binding grooveMHC class II binding grooveMHC class II antigen-binding groove

Blocking peptide loading (e.g. CLIP peptide, invariant chain interactions)[10] Modulating antigen presentation (e.g. via immunosuppressive drugs affecting antigen-presenting cell function)